FSHD / OPMD / MYOTONIC DYSTROPHY: P.229 Open-Label study of losmapimod evaluating safety, tolerability, and changes in biomarker and clinical outcome assessments in subjects with FSHD1

Detalles Bibliográficos
Autores principales: Mellion, M., Kools, J., Mul, K., Ronco, L., Odueyungbo, A., Marshall, K., van Engelen, B., Cadavid, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521204/
http://dx.doi.org/10.1016/j.nmd.2020.08.228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521204/
http://dx.doi.org/10.1016/j.nmd.2020.08.228

Ejemplares similares